Biofrontera Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -37.71M-0.64M-20.13M-17.76M
Depreciation and Depletion 0.12M0.10M0.09M0.09M
Share-based Compensation 0.13M1.85M1.04M1.02M
Gains from Sales and Divestitures 0.01M0.01M0.00M
Gains from Investment Securities 0.62M0.09M0.10M1.36M
Asset Writedowns and Impairment 0.04M0.11M0.12M0.16M
Non-cash Items 1.69M222.83M0.03M0.01M
Cash from Operations -26.71M-16.20M-24.90M-10.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.42M0.65M0.56M0.73M
Depreciation & Amortization (CF) 0.12M0.10M0.60M0.60M
Change in Working Capital
Change in Receivables 0.61M0.07M1.54M0.32M
Change in Inventory -2.59M2.81M3.75M-4.23M
Change in Account Payables 4.39M-1.45M
Change in Accured Expenses 12.48M-3.61M-6.35M-0.23M
Other Working Capital Changes 3.81M-4.15M5.16M-5.16M
Investing Activities
Capital Expenditures 0.01M0.04M0.01M0.01M
Change in Intangibles 0.05M
Change in Acquisitions & Divestments 0.62M0.10M
Cash from Investing Activities -0.01M-5.16M0.62M-0.00M
Financing Activities
Cash from Financing Activities 43.19M14.02M8.41M14.84M
Additional items
Change in Cash 16.46M-7.33M-15.87M4.56M
Beginning Cash Balance 8.10M8.08M24.54M17.21M1.34M
Free Cash Flow -26.73M-16.24M-24.91M-10.31M
Net Cash Flow 16.46M-7.33M-15.87M4.53M